OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
1-Year Return
4.17%
This Quarter Return
-4.19%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$104M
AUM Growth
+$141K
(+0.14%)
Cap. Flow
+$7.78M
Cap. Flow
% of AUM
7.48%
Top 10 Holdings %
Top 10 Hldgs %
45.14%
Holding
61
New
12
Increased
25
Reduced
1
Closed
5
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$1.64M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$1.35M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.33M |
| 4 |
Bristol-Myers Squibb
BMY
|
$837K |
| 5 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$322K |
Top Sells
| 1 |
ProShares UltraShort S&P500
SDS
|
$656K |
| 2 |
CPHD
Cepheid Inc
CPHD
|
$315K |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$311K |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$208K |
| 5 |
Novavax
NVAX
|
$54K |
Sector Composition
| 1 | Healthcare | 75.87% |
| 2 | Real Estate | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Myriad Genetics
MYGN
$632M
| $232K | 0.18% |
+13,907
| New | +$232K |
|
|
ICPT
52
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $232K | 0.18% |
2,135
+829
| +63% | +$90.1K |
|
|
JUNO
53
DELISTED
Juno Therapeutics, Inc.
JUNO
| $216K | 0.17% |
11,478
+4,560
| +66% | +$85.8K |
|
54
Seres Therapeutics
MCRB
$165M
| $139K | 0.11% |
700
| – | – |
|
55
iShares Russell 2000 ETF
IWM
$67.4B
| – | – |
0
| – | – |
|
56
Eli Lilly
LLY
$666B
| – | – |
0
| – | – |
|
|
57
Novavax
NVAX
$1.27B
| – | – |
-1,289
| Closed | -$54K |
|
|
58
ProShares UltraShort S&P500
SDS
$439M
| – | – |
-2,000
| Closed | -$656K |
|
|
ISEE
59
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-6,746
| Closed | -$311K |
|
|
SIOX
60
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| – | – |
-1,856
| Closed | -$208K |
|
|
CPHD
61
DELISTED
Cepheid Inc
CPHD
| – | – |
-5,985
| Closed | -$315K |
|